Comparison of survival between patients with hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 2, 2009, Pages 209-212

  Haghighi, Mahdi Montazer ^a   Vahedi, Mohsen ^a   Mohebbi, Seyed Reza ^a   Pourhoseingholi, Mohamad Amin ^a   Fatemi, Seyed Reza ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Comparison; HNPCC; Sporadic colorectal cancer; Survival

Indexed keywords

EID: 67650891896     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Aaltonen LA, Salovaara R, Kristo P, et al (1998). Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. New Engl J Med, 338, 1481-7.
2. Aarnio M, Mecklin JP, Aaltonen LA, et al (1995). Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer, 64, 430-3.
3. Azadeh S, Moghimi-Dehkordi B, Fatem SR, et al (2008). Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
4. Barnetson R, Tenesa A, Farrington SM, et al (2006). Identification and survival of carriers of mutations in DNA Mismatch-repairs genes in Colon cancer. N Engl J Med, 354, 2751-63.
5. Barrow E, Alduaij W, Robinson L, et al (2008). Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet, 74, 233-42.
6. Boyle P, Langman JS (2000). ABC of colorectal cancer: epidemiology. BMJ, 321, 805-8.
7. Cusack JC, Giacco GG, Cleary K, et al (1996). Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg, 183, 105-12.
8. Elsakov P, K Urtinaitis J (2006). Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania-initial results. Fam Cancer, 5, 369-71.
9. Frattini M, Balestra D, Suardi S, et al (2004). Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res, 10, 4015-21.
10. Dionigi G, Bianchi V, Rovera F, et al (2007). Genetic alteration in hereditary colorectal cancer. Surg Oncol, 16, S11-S15.
11. Giardiello FM. (1995). Gastrointestinal polyposis syndromes and hereditary nonpolyposis colorectal cancer. In: Rustgi A, editor. Gastrointestinal cancers: biology, diagnosis, and therapy. New York: Ravin Press.
12. Hosseini SV, Izadpanah A, Yarmohammadi H (2004). Epidemiological changes in colorectal cancer in Shiraz, Iran: 1980-2000. ANZ J Surg, 74, 547-49.
13. Kleinbaum D, Kupper L (1978). Applied regression analysis another multi variable method. Duxburg, Boston, 188-09.
14. Lynch HT, Smyrk TC, Watson P, et al (1993). Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposiscolorectal cancer: an updated review. Gastroenterology, 104, 1535-49.
15. Lynch HT, Smirk TC (1996). Hereditary nonpolyposis colorectal cancer (Lynch syndrome): updated review. Cancer, 78, 1149-67.
16. Moghimi-Dehkordi B, Safaee A, Zali MR (2008). Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Colorectal Dis, 23, 683-8.
17. Myrhoj T, Bisgaard ML, Bernstein I, et al (1997). Hereditary non-polyposis colorectal cancer:clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol, 32, 572-76.
18. Nishisho I, Nakamura Y, Miyosshi Y, et al (1991). Mutation of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253, 665-9.
19. Percesepe A, Benatti P, Roncucci L, et al (1997). Survival analysis in families affected by hereditary non polyposis colorectal cancer. Int J Cancer, 71, 373-76.
20. Phillips RK, Hittinger R, Blesovsky L, et al (1984). Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg, 71, 604-10.
21. Rodriquez-Bigas MA, Boland CR, Hamilton SR, et al (1997). A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst, 89, 1758-62.
22. Sankila R, Aaltonen LA, Jarvinen HJ, et al (1996). Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology, 110, 682-87.
23. Takahashi K, Mori T, Yasuno M (2000). Histologic grade of metastatic lymph node and prognosis of rectal cancer. Dis Colon Rectum, 43, S40-S6.
24. Valle L, Perea J, Carbonell P, et al (2007). Clinicopathologic and pedigree differences in Amsterdam I-positive Hereditary Nonpolyposis Colorectal Cancer Families According to tumor microsatellite instability status. J Clin Oncol, 25, 781-86.
25. Vasen HFA, Wijnen JT, Menko FH, et al (1996).Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110, 1020-7.
26. Vasen HF, Watson P, Mecklin JP, et al (1999). New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology, 116, 1453-6.
27. Vasen HF, Moslein G, Alonso A, et al (2007) .Guidelines for the clinical management of Lynch Syndrome (HNPCC). J Med Genet, 44, 353-62.
28. Watson P, Lin KM, Rodriguez-Bigas MA, et al (1998).Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer, 83, 259-66.
29. Young J, Simms LA, Biden KG, et al (2001).Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis. Am J Pathol, 159, 2107-16.